Selexis the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative biologic medicines and vaccines.
Products, services, technology
Our global partners utilize Selexis technologies to advance over 145 drug products in preclinical and clinical development and the manufacture of 9 commercial products.
With our timelines, we can help you achieve faster time-to-market, lowering the manufacturing cost of your promising candidates.
Selexis offers contract development and maintenance of high-performance mammalian cell lines used in the expression of pharmaceutically relevant proteins (mAbs, recombinant proteins). Selexis has interactive partnerships with some of the world's leading biotech, pharma and CMO companies.